Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan

被引:92
作者
De Leyn, P [1 ]
Vansteenkiste, J [1 ]
Cuypers, P [1 ]
Deneffe, G [1 ]
Van Raemdonck, D [1 ]
Coosemans, W [1 ]
Verschakelen, J [1 ]
Lerut, T [1 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Thorac Surg, B-3000 Louvain, Belgium
关键词
mediastinoscopy; N2; disease; specificity; carcinoma; non-small cell lung; lung surgery;
D O I
10.1016/S1010-7940(97)00253-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The results of primary surgery for non-small cell lung cancer (NSCLC) with involved ipsilateral mediastinal or subcarinal lymph nodes (N2 disease) remains poor. However, several studies suggest that induction chemotherapy could increase long-term survival in patients with N2 disease, Therefore, accurate preoperative staging of the mediastinum remains of paramount importance for the treatment policy in patients with NSCLC. Enlarged mediastinal lymph nodes (MLN) on CT scan are positive in only half of the patients. Small lymph nodes can contain metastatic deposits of clinical importance. However, many surgeons believe that a normal mediastinum at computed tomography allows them to cancel their preoperative mediastinal exploration. It was the aim of this study to evaluate the results of cervical mediastinoscopy in patients without enlarged MLN on CT scan. Methods: Between January 1990 and June 1994, 235 patients with potentially operable NSCLC underwent a cervical mediastinoscopy despite the absence of enlarged MLN on CT scan, MLN were considered enlarged if they were equal to or larger than 15 mm at their maximal cross-sectional diameter. Results: Cervical mediastinoscopy was positive in 47 patients (20%), In 21 patients, N2 disease was extranodal and in 16 patients more than one level was involved. Mediastinoscopy was positive in 9.5% of the cT1NO cases, in 17.7% of the cT2NO lesions, in 31.2 and 33.3% of cT3NO or cT4NO tumors. respectively. After a negative cervical mediastinoscopy, resectability for unforeseen N2 disease was as high as 95%. Conclusion: We recommend a cervical mediastinoscopy in every patient with potentially operable NSCLC. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:706 / 712
页数:7
相关论文
共 50 条
  • [31] MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial
    Jelle E. Bousema
    Marcel G. W. Dijkgraaf
    Nicole E. Papen-Botterhuis
    Hermien W. Schreurs
    Jos G. Maessen
    Erik H. van der Heijden
    Willem H. Steup
    Jerry Braun
    Valentin J. J. M. Noyez
    Fieke Hoeijmakers
    Naomi Beck
    Martijn van Dorp
    Niels J. M. Claessens
    Birgitta I. Hiddinga
    Johannes M. A. Daniels
    David J. Heineman
    Harmen R. Zandbergen
    Ad F. T. M. Verhagen
    Paul E. van Schil
    Jouke T. Annema
    Frank J. C. van den Broek
    BMC Surgery, 18
  • [32] Is there still a role for mediastinoscopy as the first mediastinal staging procedure in lung cancer?
    Waller, D.
    Skwarski, K. M.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2013, 43 (02) : 137 - 140
  • [33] MEDIASTINAL STAGING OF LUNG-CANCER - THE CHANGING-ROLE OF MEDIASTINOSCOPY
    WEISSBERG, D
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1995, 31 (2-3): : 122 - 124
  • [34] Endobronchial ultrasound (EBUS) with tranbronchial needle aspiration (TBNA) versus mediastinoscopy for mediastinal staging in non-small cell lung cancer (NSCLC) thoracic cancer
    Nasir, Basil
    Cerfolio, Robert J.
    Bryant, Ayesha S.
    THORACIC CANCER, 2012, 3 (02) : 131 - 138
  • [35] Mediastinal staging of non-small-cell lung cancer
    Dhillon, Samjot Singh
    Dhillon, Jaspreet Kaur
    Yendamuri, Sai
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (06) : 835 - 851
  • [36] Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)
    Sanchez Sanchez, R.
    Rodriguez Fernandez, A.
    Gomez Rio, M.
    Alkurdi Martinez, A.
    Castellon Rubio, V. E.
    Ramos Font, C.
    Sanchez-Palencia Ramos, A.
    Delgado Perez, J. R.
    Llamas Elvira, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (04): : 211 - 216
  • [37] Current Status of Mediastinal Lymph Node Dissection Versus Sampling in Non-small Cell Lung Cancer
    Darling, Gail E.
    THORACIC SURGERY CLINICS, 2013, 23 (03) : 349 - +
  • [38] ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer
    De Leyn, Paul
    Lardinois, Didier
    Van Schil, Paul E.
    Rami-Porta, Ramon
    Passlick, Bernward
    Zielinski, Marcin
    Walter, David A.
    Lerut, Tony
    Weder, Walter
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (01) : 1 - 8
  • [39] Minimally Invasive with Maximal Yield: A Narrative Review of Current Practices in Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer
    Rodriguez, Gustavo R.
    Trachiotis, Gregory D.
    Mullenix, Philip S.
    Antevil, Jared L.
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2024, 34 (09): : 773 - 785
  • [40] Performance insights of endobronchial ultrasonography (EBUS) and mediastinoscopy for mediastinal lymph node staging in lung cancer
    Visser, M. P. J.
    van Grimbergen, I
    Holters, J.
    Barendregt, W. B.
    Vermeer, L. C.
    Vreuls, W.
    Janssen, J.
    LUNG CANCER, 2021, 156 : 122 - 128